We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Agalimmune Receives £1.2 million ($2 million) Milestone Payment

News   Jun 04, 2014

 
Agalimmune Receives £1.2 million ($2 million) Milestone Payment
 
 
Advertisement
 

RELATED ARTICLES

Complex Role of Immune Molecule in Huntington’s Disease

News

Abnormally high levels of an immune-system molecule, interleukin-6 (IL-6), prior to Huntington’s disease symptoms suggested it led to disease progression. However, Huntington’s model mice bred to lack IL-6 showed exacerbated symptoms compared to mice that still had it, indicating a complex relationship.

READ MORE

How A Protein Can Inhibit Cancer Development in Mice

News

Researchers have discovered how the protein PP2A can inhibit tumor growth in mice.

READ MORE

Trial Investigates Remdesivir–Baricitinib Combo as COVID-19 Treatment

News

Following on from remdesivir’s promising results from previous studies, a new trial is now investigating remdesivir in combination with baricitinib or placebo as a treatment for COVID-19, in a double-blind, randomized trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE